Appropriate sample size for standardization parameters estimation reduces misdiagnoses of molecular-based risk predictors in breast cancer
Artículo
Material complementario disponible
Artículo
CONICET Digital
Background: Accurate risk/outcome prediction, in which molecular signatures (MS) are playing an increasingly important role, is crucial for personalized therapy. Patients require an accurate diagnosis and an appropriate ...
Idioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario